{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T07:26:46Z","timestamp":1778830006452,"version":"3.51.4"},"reference-count":128,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.lfs.2020.118834","type":"journal-article","created":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T12:08:53Z","timestamp":1606392533000},"page":"118834","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["\u201cAdenosine an old player with new possibilities in kidney diseases\u201d: Preclinical evidences and clinical perspectives"],"prefix":"10.1016","volume":"265","author":[{"given":"Sneha","family":"Pandey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devesh","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirti","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abha","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pallavi","family":"Sen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ragini","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jagdish Chandar","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vir Vikram","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamalpreet","family":"Mehra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaaminepreet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lfs.2020.118834_bb0005","first-page":"14","article-title":"Adenosine generation and signaling during acute kidney injury","volume":"22","author":"Bauerle","year":"2011","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"3","key":"10.1016\/j.lfs.2020.118834_bb0010","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0014-2999(02)01510-8","article-title":"Cisplatin up-regulates the adenosine A1 receptor in the rat kidney","volume":"442","author":"Bhat","year":"2002","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.lfs.2020.118834_bb0015","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1476-5381.1991.tb12550.x","article-title":"Amelioration of cisplatin- induced acute renal failure with 8- cyclopentyl- 1, 3- dipropylxanthine","volume":"104","author":"Knight","year":"1991","journal-title":"Br. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.lfs.2020.118834_bb0020","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.3346\/jkms.2016.31.9.1403","article-title":"Renoprotective effects of a highly selective A3 adenosine receptor antagonist in a mouse model of adriamycin-induced nephropathy","volume":"31","author":"Min","year":"2016","journal-title":"J. Korean Med. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2020.118834_bb0025","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3109\/03009734.2013.851748","article-title":"Activation of adenosine receptors improves renal antioxidant status in diabetic Wistar but not SHR rats","volume":"119","author":"Patinha","year":"2014","journal-title":"Ups. J. Med. Sci."},{"issue":"2","key":"10.1016\/j.lfs.2020.118834_bb0030","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1161\/01.HYP.17.2.117","article-title":"Adenosine receptors and signaling in the kidney","volume":"17","author":"Spielman","year":"1991","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.lfs.2020.118834_bb0035","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/MNH.0b013e32834d2ec9","article-title":"Adenosine and protection from acute kidney injury","volume":"21","author":"Yap","year":"2012","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"1","key":"10.1016\/j.lfs.2020.118834_bb0040","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/01.ASN.0000102474.68613.AE","article-title":"A1 adenosine receptor activation inhibits inflammation, necrosis, and apoptosis after renal ischemia-reperfusion injury in mice","volume":"15","author":"Lee","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.lfs.2020.118834_bb0045","first-page":"339","article-title":"Adenosine signaling increases proinflammatory and profibrotic mediators through activation of a functional adenosine 2B receptor in renal fibroblasts","volume":"46","author":"Wilkinson","year":"2016","journal-title":"Ann. Clin. Lab. Sci."},{"issue":"4","key":"10.1016\/j.lfs.2020.118834_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0053-x","article-title":"Orally active, species-independent novel A 3 adenosine receptor antagonist protects against kidney injury in db\/db mice","volume":"50","author":"Dorotea","year":"2018","journal-title":"Exp. Mol. Med."},{"issue":"11","key":"10.1016\/j.lfs.2020.118834_bb0055","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1161\/hc1102.105264","article-title":"BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy","volume":"105","author":"Gottlieb","year":"2002","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.lfs.2020.118834_bb0060","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1016\/j.jacc.2010.11.057","volume":"57","author":"Voors","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.lfs.2020.118834_bb0065","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2165\/11594680-000000000-00000","article-title":"The safety of an adenosine A 1-receptor antagonist, rolofylline, in patients with acute heart failure and renal impairment","volume":"35","author":"Teerlink","year":"2012","journal-title":"Drug Saf."},{"issue":"3","key":"10.1016\/j.lfs.2020.118834_bb0070","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11302-012-9305-8","article-title":"ATP synthesis and storage","volume":"8","author":"Bonora","year":"2012","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.lfs.2020.118834_bb0075","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1146\/annurev.immunol.22.012703.104731","article-title":"Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors","volume":"22","author":"Sitkovsky","year":"2004","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.lfs.2020.118834_bb0080","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1042\/BST20160038","article-title":"The SLC28 (CNT) and SLC29 (ENT) nucleoside transporter families: a 30-year collaborative odyssey","volume":"44","author":"Young","year":"2016","journal-title":"Biochem. Soc. Trans."},{"issue":"2","key":"10.1016\/j.lfs.2020.118834_bb0085","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0014-2999(87)90443-2","article-title":"Visualization of adenosine A1 receptors in the human and the guinea-pig kidney","volume":"138","author":"Palacios","year":"1987","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.lfs.2020.118834_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0026-895X(25)12833-2","article-title":"Cloning and expression of an A1 adenosine receptor from rat brain","volume":"40","author":"Mahan","year":"1991","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.lfs.2020.118834_bb0095","doi-asserted-by":"crossref","first-page":"F41","DOI":"10.1152\/ajprenal.00232.2001","article-title":"Expression of adenosine receptors in the preglomerular microcirculation","volume":"283","author":"Jackson","year":"2002","journal-title":"American Journal of Physiology-Renal Physiology"},{"issue":"6","key":"10.1016\/j.lfs.2020.118834_bb0100","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1474-8673.1996.tb00057.x","article-title":"Role of adenosine in tubuloglomerular feedback and acute renal failure","volume":"16","author":"Osswald","year":"1996","journal-title":"J. Auton. Pharmacol."},{"issue":"5","key":"10.1016\/j.lfs.2020.118834_bb0105","first-page":"R1362","article-title":"Abolished tubuloglomerular feedback and increased plasma renin in adenosine A1 receptor- deficient mice","volume":"281","author":"Brown","year":"2001","journal-title":"Am. J. Phys. Regul. Integr. Comp. Phys."},{"issue":"3","key":"10.1016\/j.lfs.2020.118834_bb0110","first-page":"R854","article-title":"Adenosine signaling in outer medullary descending vasa recta","volume":"280","author":"Silldorff","year":"2001","journal-title":"Am. J. Phys. Regul. Integr. Comp. Phys."},{"issue":"8","key":"10.1016\/j.lfs.2020.118834_bb0115","doi-asserted-by":"crossref","first-page":"F1209","DOI":"10.1152\/ajprenal.00710.2012","article-title":"Adenosine inhibits renin release from juxtaglomerular cells via an A1 receptor-TRPC-mediated pathway","volume":"305","author":"Ortiz-Capisano","year":"2013","journal-title":"American Journal of Physiology-Renal Physiology"},{"issue":"6","key":"10.1016\/j.lfs.2020.118834_bb0120","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/ki.1989.126","article-title":"Adenosine induces mesangial cell contraction by an A1-type receptor","volume":"35","author":"Olivera","year":"1989","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.lfs.2020.118834_bb0125","doi-asserted-by":"crossref","first-page":"F511","DOI":"10.1152\/ajprenal.1993.265.4.F511","article-title":"Regulation of Na (+)- 3HCO3-cotransport in rabbit proximal convoluted tubule via adenosine A1 receptor","volume":"265","author":"Takeda","year":"1993","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"5","key":"10.1016\/j.lfs.2020.118834_bb0130","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1681\/ASN.V651491","article-title":"Adenosine and renal sodium handling: direct natriuresis and renal nerve-mediated antinatriuresis","volume":"6","author":"Fransen","year":"1995","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.lfs.2020.118834_bb0135","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1113\/jphysiol.2001.013438","article-title":"Molecular aspects of acute inhibition of Na+\u2212 H+ exchanger NHE3 by A2- adenosine receptor agonists","volume":"541","author":"Di Sole","year":"2002","journal-title":"J. Physiol."},{"issue":"7","key":"10.1016\/j.lfs.2020.118834_bb0140","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1097\/01.ASN.0000072743.97583.DB","article-title":"Bimodal acute effects of A1 adenosine receptor activation on Na+\/H+ exchanger 3 in opossum kidney cells","volume":"14","author":"Di Sole","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.lfs.2020.118834_bb0145","doi-asserted-by":"crossref","first-page":"F791","DOI":"10.1152\/ajprenal.1994.266.5.F791","article-title":"Adenosine A1 receptor-mediated inhibition of vasopressin action in inner medullary collecting duct","volume":"266","author":"Edwards","year":"1994","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"1","key":"10.1016\/j.lfs.2020.118834_bb0150","doi-asserted-by":"crossref","first-page":"F103","DOI":"10.1152\/ajprenal.1995.269.1.F103","article-title":"Hypertonic NaCl enhances adenosine release and hormonal cAMP production in mouse thick ascending limb","volume":"269","author":"Baudouin-Legros","year":"1995","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"3","key":"10.1016\/j.lfs.2020.118834_bb0155","doi-asserted-by":"crossref","first-page":"F361","DOI":"10.1152\/ajprenal.1992.262.3.F361","article-title":"Effect of mesangiolysis on autoregulation of renal blood flow and glomerular filtration rate in rats","volume":"262","author":"Iversen","year":"1992","journal-title":"Am J Physiol Renal"},{"issue":"4","key":"10.1016\/j.lfs.2020.118834_bb0160","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/ki.1991.264","article-title":"Effect of mesangial cell lysis and proliferation on glomerular hemodynamics in the rat","volume":"40","author":"Yamamoto","year":"1991","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.lfs.2020.118834_bb0165","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/0272-6386(95)90065-9","article-title":"Chemokines and renal disease","volume":"26","author":"Wenzel","year":"1995","journal-title":"Am. J. Kidney Dis."},{"issue":"6","key":"10.1016\/j.lfs.2020.118834_bb0170","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/ki.1989.126","article-title":"Adenosine induces mesangial cell contraction by an A1-type receptor","volume":"35","author":"Olivera","year":"1989","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.lfs.2020.118834_bb0175","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/BF01928895","article-title":"A 2 adenosine receptors in human glomerular mesangial cells","volume":"51","author":"Stefanovi\u0107","year":"1995","journal-title":"Experientia"},{"issue":"1","key":"10.1016\/j.lfs.2020.118834_bb0180","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0898-6568(96)00091-5","article-title":"Adenosine activates mesangial cell proliferation","volume":"9","author":"MacLaughlin","year":"1997","journal-title":"Cell. Signal."},{"issue":"5","key":"10.1016\/j.lfs.2020.118834_bb0185","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1172\/JCI117565","article-title":"Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis","volume":"94","author":"Baker","year":"1994","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.lfs.2020.118834_bb0190","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1046\/j.1523-1755.2002.00256.x","article-title":"Adenosine-induced apoptosis in glomerular mesangial cells","volume":"61","author":"Zhao","year":"2002","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.lfs.2020.118834_bb0195","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1161\/01.HYP.0000183963.07801.65","article-title":"Blood pressure\u2013dependent inhibition of renin secretion requires A1 adenosine receptors","volume":"46","author":"Schweda","year":"2005","journal-title":"Hypertension"},{"issue":"8","key":"10.1016\/j.lfs.2020.118834_bb0200","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0024-3205(79)90510-1","article-title":"Inhibition of in vitro renin release by low extracellular K","volume":"25","author":"Churchill","year":"1979","journal-title":"Life Sci."},{"issue":"15","key":"10.1016\/j.lfs.2020.118834_bb0205","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/0024-3205(82)90694-4","article-title":"Isoproterenol-stimulated renin secretion in the rat: second messenger roles of Ca and cyclic AMP","volume":"30","author":"Churchill","year":"1982","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2020.118834_bb0210","doi-asserted-by":"crossref","unstructured":"Ali, T. and Roderick, P., 2010. Epidemiology of acute kidney injury. In Management of Acute Kidney Problems (pp. 63\u201373). Springer, Berlin, Heidelberg.","DOI":"10.1007\/978-3-540-69441-0_7"},{"issue":"1","key":"10.1016\/j.lfs.2020.118834_bb0215","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/ki.2012.352","article-title":"Spironolactone prevents chronic kidney disease caused by ischemic acute kidney injury","volume":"83","author":"Barrera-Chimal","year":"2013","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.lfs.2020.118834_bb0220","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/ki.1996.380","article-title":"Epidemiology of acute renal failure: a prospective, multicenter, community-based study","volume":"50","author":"Liano","year":"1996","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.lfs.2020.118834_bb0225","first-page":"20","article-title":"Renal ischemia\/reperfusion injury; from pathophysiology to treatment","volume":"4","author":"Malek","year":"2015","journal-title":"J Renal Inj Prev."},{"issue":"6","key":"10.1016\/j.lfs.2020.118834_bb0230","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1681\/ASN.2006010017","article-title":"Update of mechanisms of ischemic acute kidney injury","volume":"17","author":"Devarajan","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"issue":"7","key":"10.1016\/j.lfs.2020.118834_bb0235","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/ki.2008.648","article-title":"Compartmentalization of neutrophils in the kidney and lung following acute ischemic kidney injury","volume":"75","author":"Awad","year":"2009","journal-title":"Kidney Int."},{"issue":"12","key":"10.1016\/j.lfs.2020.118834_bb0240","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1038\/ki.2008.500","article-title":"The chemokine receptors CCR2 and CX3CR1 mediate monocyte\/macrophage trafficking in kidney ischemia-reperfusion injury","volume":"74","author":"Li","year":"2008","journal-title":"Kidney Int."},{"issue":"7","key":"10.1016\/j.lfs.2020.118834_bb0245","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/sj.ki.5002132","article-title":"Resident dendritic cells are the predominant TNF-secreting cell in early renal ischemia\u2013reperfusion injury","volume":"71","author":"Dong","year":"2007","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.lfs.2020.118834_bb0250","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.semnephrol.2010.03.005","article-title":"Macrophages, dendritic cells and kidney ischemia-reperfusion injury","volume":"30","author":"Li","year":"2010","journal-title":"Semin. Nephrol."},{"issue":"1","key":"10.1016\/j.lfs.2020.118834_bb0255","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/01.ASN.0000102474.68613.AE","article-title":"A1 adenosine receptor activation inhibits inflammation, necrosis, and apoptosis after renal ischemia-reperfusion injury in mice","volume":"15","author":"Lee","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.lfs.2020.118834_bb0260","doi-asserted-by":"crossref","first-page":"F1847","DOI":"10.1152\/ajprenal.00336.2007","article-title":"Acute and delayed renal protection against renal ischemia and reperfusion injury with A1 adenosine receptors","volume":"293","author":"Joo","year":"2007","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"8","key":"10.1016\/j.lfs.2020.118834_bb0265","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/ki.2012.224","article-title":"Proximal tubule sphingosine kinase-1 has a critical role in A1 adenosine receptor-mediated renal protection from ischemia","volume":"82","author":"Park","year":"2012","journal-title":"Kidney Int."},{"issue":"7","key":"10.1016\/j.lfs.2020.118834_bb0270","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s11255-018-1797-x","article-title":"A1AR-mediated renal protection against ischemia\/reperfusion injury is dependent on HSP27 induction","volume":"50","author":"Xiong","year":"2018","journal-title":"Int. Urol. Nephrol."},{"issue":"7","key":"10.1016\/j.lfs.2020.118834_bb0275","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1113\/EP085583","article-title":"A1- Adenosine receptor activation has biphasic roles in development of acute kidney injury at 4 and 24 h of reperfusion following ischaemia in rats","volume":"101","author":"Najafi","year":"2016","journal-title":"Exp. Physiol."},{"issue":"2","key":"10.1016\/j.lfs.2020.118834_bb0280","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0021-5198(19)35776-2","article-title":"Protective effects of KW-3902, a novel adenosine A1-receptor antagonist, against gentamicin-induced acute renal failure in rats","volume":"65","author":"Yao","year":"1994","journal-title":"The Jpn. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.lfs.2020.118834_bb0285","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1159\/000248762","article-title":"Protective effect of tonapofylline (BG9928), an adenosine A1 receptor antagonist, against cisplatin-induced acute kidney injury in rats","volume":"30","author":"Gill","year":"2009","journal-title":"Am. J. Nephrol."},{"issue":"6","key":"10.1016\/j.lfs.2020.118834_bb0290","doi-asserted-by":"crossref","first-page":"F1367","DOI":"10.1152\/ajprenal.00347.2005","article-title":"A1 adenosine receptor knockout mice are protected against acute radiocontrast nephropathy in vivo","volume":"290","author":"Lee","year":"2006","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"3","key":"10.1016\/j.lfs.2020.118834_bb0295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017891","article-title":"Renal effects of the novel selective adenosine A1 receptor blocker SLV329 in experimental liver cirrhosis in rats","volume":"6","author":"Hocher","year":"2011","journal-title":"PLoS One"},{"issue":"15","key":"10.1016\/j.lfs.2020.118834_bb0300","doi-asserted-by":"crossref","first-page":"4026","DOI":"10.1158\/1078-0432.CCR-14-0319","article-title":"Cisplatin-induced renal injury is independently mediated by OCT2 and p53","volume":"20","author":"Sprowl","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.lfs.2020.118834_bb0305","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1039\/c3ib40049b","article-title":"Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment","volume":"5","author":"Jang","year":"2013","journal-title":"Integr. Biol."},{"issue":"5","key":"10.1016\/j.lfs.2020.118834_bb0310","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.lfs.2003.08.001","article-title":"Pathogenesis of renal ischemia\/reperfusion injury: lessons from knockout mice","volume":"74","author":"Lien","year":"2003","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.lfs.2020.118834_bb0315","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1159\/000490338","article-title":"Tempol protects against acute renal injury by regulating PI3K\/Akt\/mTOR and GSK3\u03b2 signaling cascades and afferent arteriolar activity","volume":"43","author":"Zhang","year":"2018","journal-title":"Kidney Blood Press R"},{"issue":"10","key":"10.1016\/j.lfs.2020.118834_bb0320","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1097\/01.ASN.0000086474.80845.25","article-title":"Adenosine induces vasoconstriction through Gi-dependent activation of phospholipase C in isolated perfused afferent arterioles of mice","volume":"14","author":"Hansen","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.lfs.2020.118834_bb0325","doi-asserted-by":"crossref","first-page":"F380","DOI":"10.1152\/ajprenal.2000.278.3.F380","article-title":"Protective effects of renal ischemic preconditioning and adenosine pretreatment: role of A1 and A3receptors","volume":"278","author":"Lee","year":"2000","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"6","key":"10.1016\/j.lfs.2020.118834_bb0330","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1046\/j.1464-410X.1997.00209.x","article-title":"Ischaemia- reperfusion injury in the rat kidney: the effect of preconditioning","volume":"79","author":"Islam","year":"1997","journal-title":"Br. J. Urol."},{"issue":"2","key":"10.1016\/j.lfs.2020.118834_bb0335","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1254\/jjp.87.134","article-title":"Role of adenosine in renal protection induced by a brief episode of ischemic preconditioning in rats","volume":"87","author":"Sugino","year":"2001","journal-title":"Jpn. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.lfs.2020.118834_bb0340","doi-asserted-by":"crossref","first-page":"F10","DOI":"10.1152\/ajprenal.2002.282.1.F10","article-title":"A2A adenosine receptor: a novel therapeutic target in renal disease","volume":"282","author":"Okusa","year":"2002","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"2","key":"10.1016\/j.lfs.2020.118834_bb0345","doi-asserted-by":"crossref","first-page":"F347","DOI":"10.1152\/ajprenal.00194.2010","article-title":"Selective renal overexpression of human heat shock protein 27 reduces renal ischemia-reperfusion injury in mice","volume":"299","author":"Kim","year":"2010","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"3","key":"10.1016\/j.lfs.2020.118834_bb0350","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1152\/physrev.00031.2005","article-title":"Adenosine and kidney function","volume":"86","author":"Vallon","year":"2006","journal-title":"Physiol. Rev."},{"issue":"4","key":"10.1016\/j.lfs.2020.118834_bb0355","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/j.1523-1755.2004.00490.x","article-title":"Gene expression of adenosine receptors along the nephron","volume":"65","author":"Vitzthum","year":"2004","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.lfs.2020.118834_bb0360","doi-asserted-by":"crossref","first-page":"F802","DOI":"10.1152\/ajprenal.1993.265.6.F802","article-title":"Disparate effects of adenosine A1-and A2-receptor agonists on intrarenal blood flow","volume":"265","author":"Agmon","year":"1993","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"12 Pt 2","key":"10.1016\/j.lfs.2020.118834_bb0365","first-page":"1753","article-title":"Effects of adenosine-receptor agonists on renin release in anaesthetized rats","volume":"13","author":"Protasoni","year":"1995","journal-title":"J. Hypertens."},{"issue":"39","key":"10.1016\/j.lfs.2020.118834_bb0370","doi-asserted-by":"crossref","first-page":"37545","DOI":"10.1074\/jbc.M302809200","article-title":"The adenosine A2A receptor interacts with the actin-binding protein \u03b1-actinin","volume":"278","author":"Burgue\u00f1o","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.lfs.2020.118834_bb0375","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/01.LAB.0000017168.26718.16","article-title":"Podocyte-associated molecules in puromycin aminonucleoside nephrosis of the rat","volume":"82","author":"Luimula","year":"2002","journal-title":"Lab. Investig."},{"issue":"4","key":"10.1016\/j.lfs.2020.118834_bb0380","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/ki.2014.244","article-title":"The role of adenosine receptors A2A and A2B signaling in renal fibrosis","volume":"86","author":"Roberts","year":"2014","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.lfs.2020.118834_bb0385","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1096\/fj.07-8430com","article-title":"Adenosine A2A receptor activation and macrophage-mediated experimental glomerulonephritis","volume":"22","author":"Garcia","year":"2008","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.lfs.2020.118834_bb0390","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/ki.2011.101","article-title":"Adenosine A2A receptor activation prevents progressive kidney fibrosis in a model of immune-associated chronic inflammation","volume":"80","author":"Garcia","year":"2011","journal-title":"Kidney Int."},{"issue":"10","key":"10.1016\/j.lfs.2020.118834_bb0395","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1016\/j.ajpath.2016.06.017","article-title":"Macrophage A2A adenosine receptors are essential to protect from progressive kidney injury","volume":"186","author":"Truong","year":"2016","journal-title":"Am. J. Pathol."},{"issue":"10","key":"10.1016\/j.lfs.2020.118834_bb0400","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1681\/ASN.2016040415","article-title":"Current and emerging therapies for lupus nephritis","volume":"27","author":"Parikh","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.lfs.2020.118834_bb0405","doi-asserted-by":"crossref","unstructured":"Matsuo, S., 2014. Regadenoson: An adenosine A2A receptor agonist for pharmacological myocardial perfusion imaging. J. Cardiol. Cases, 10(2),pp.46\u201347. 10.1016%2Fj.jccase.2014.03.004.","DOI":"10.1016\/j.jccase.2014.03.004"},{"issue":"4","key":"10.1016\/j.lfs.2020.118834_bb0410","doi-asserted-by":"crossref","first-page":"F828","DOI":"10.1152\/ajprenal.00310.2005","article-title":"Adenosine A2A receptor activation attenuates inflammation and injury in diabetic nephropathy","volume":"290","author":"Awad","year":"2006","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"4","key":"10.1016\/j.lfs.2020.118834_bb0415","doi-asserted-by":"crossref","first-page":"F722","DOI":"10.1152\/ajprenal.00378.2004","article-title":"Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: role of macrophages","volume":"288","author":"Day","year":"2005","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"8","key":"10.1016\/j.lfs.2020.118834_bb0420","first-page":"5040","article-title":"A2A adenosine receptors on bone marrow-derived cells protect liver from ischemia-reperfusion injury","volume":"174","author":"Day","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.lfs.2020.118834_bb0425","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/ki.2014.219","article-title":"Reduced adenosine A2A receptor\u2013mediated efferent arteriolar vasodilation contributes to diabetes-induced glomerular hyperfiltration","volume":"87","author":"Persson","year":"2015","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.lfs.2020.118834_bb0430","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/apha.12511","article-title":"Adenosine A2A receptor stimulation prevents proteinuria in diabetic rats by promoting an anti-inflammatory phenotype without affecting oxidative stress","volume":"214","author":"Persson","year":"2015","journal-title":"Acta Physiol."},{"issue":"1","key":"10.1016\/j.lfs.2020.118834_bb0435","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3109\/03009734.2013.851748","article-title":"Activation of adenosine receptors improves renal antioxidant status in diabetic Wistar but not SHR rats","volume":"119","author":"Patinha","year":"2014","journal-title":"Ups. J. Med. Sci."},{"issue":"21","key":"10.1016\/j.lfs.2020.118834_bb0440","doi-asserted-by":"crossref","first-page":"5329","DOI":"10.3390\/ijms20215329","article-title":"Expression of adenosine receptors in rodent pancreas","volume":"20","author":"Hayashi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.lfs.2020.118834_bb0445","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217552","article-title":"Diabetes downregulates renal adenosine A2A receptors in an experimental model of hypertension","volume":"14","author":"Patinha","year":"2019","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.lfs.2020.118834_bb0450","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1038\/sj.ki.5000410","article-title":"The podocyte\u2019s response to injury: role in proteinuria and glomerulosclerosis","volume":"69","author":"Shankland","year":"2006","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.lfs.2020.118834_bb0455","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1681\/ASN.2007030276","article-title":"Activation of adenosine 2A receptors preserves structure and function of podocytes","volume":"19","author":"Awad","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.lfs.2020.118834_bb0460","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.acthis.2012.09.002","article-title":"The effects of adenosine A2A receptor knockout on renal interstitial fibrosis in a mouse model of unilateral ureteral obstruction","volume":"115","author":"Xiao","year":"2013","journal-title":"Acta Histochem."},{"key":"10.1016\/j.lfs.2020.118834_bb0465","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2016.06.012","article-title":"A-306989, an inhibitor of adenosine kinase, is renoprotective in rodent models of podocyte, basement membrane, and obstructive injury","volume":"788","author":"Zhu","year":"2016","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.lfs.2020.118834_bb0470","doi-asserted-by":"crossref","first-page":"F107","DOI":"10.1152\/ajprenal.00385.2018","article-title":"Adenosine kinase inhibition protects against cisplatin-induced nephrotoxicity","volume":"317","author":"Cao","year":"2019","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"22","key":"10.1016\/j.lfs.2020.118834_bb0475","doi-asserted-by":"crossref","first-page":"11388","DOI":"10.1016\/S0021-9258(19)86498-0","article-title":"Purification and properties of human placental adenosine kinase","volume":"254","author":"Andres","year":"1979","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2020.118834_bb0480","doi-asserted-by":"crossref","first-page":"117972","DOI":"10.1016\/j.lfs.2020.117972","article-title":"Adenosine kinase inhibition attenuates ischemia reperfusion-induced acute kidney injury","author":"Cao","year":"2020","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.lfs.2020.118834_bb0485","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0021-9258(17)35979-3","article-title":"Methionine metabolism in mammals. Adaptation to methionine excess","volume":"261","author":"Finkelstein","year":"1986","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.lfs.2020.118834_bb0490","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1161\/01.RES.66.3.754","article-title":"Localization of adenosine deaminase and adenosine deaminase complexing protein in rabbit heart. Implications for adenosine metabolism","volume":"66","author":"Schrader","year":"1990","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.lfs.2020.118834_bb0495","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/abbi.1999.1548","article-title":"Decreased expression of adenosine kinase in streptozotocin-induced diabetes mellitus rats","volume":"375","author":"Pawelczyk","year":"2000","journal-title":"Arch. Biochem. Biophys."},{"issue":"11","key":"10.1016\/j.lfs.2020.118834_bb0500","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1016\/j.bmc.2005.03.023","article-title":"5-(3-Bromophenyl)-7-(6-morpholin- 4-ylpyridin-3-yl) pyrido [2, 3-d] pyrimidin-4-ylamine: structure\u2013activity relationships of 7-substituted heteroaryl analogs as non-nucleoside adenosine kinase inhibitors","volume":"13","author":"Matulenko","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.lfs.2020.118834_bb0505","unstructured":"Erion, M.D., Wiesner, J.B., Rosengren, S., Ugarkar, B.G., Boyer, S.H., Tsuchiya, M., Nakane, M., Pettersen, B.A. and Nagahisa, A., 2000. Therapeutic potential of adenosine kinase inhibitors as analgesic agents. Drug Dev. Res., 50, pp.S14-06."},{"key":"10.1016\/j.lfs.2020.118834_bb0510","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.lfs.2019.01.017","article-title":"Spironolactone inhibits endothelial-mesenchymal transition via the adenosine A2A receptor to reduce cardiorenal fibrosis in rats","volume":"224","author":"Chen","year":"2019","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.lfs.2020.118834_bb0515","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1161\/01.HYP.0000178464.63393.88","article-title":"Adenosine inhibits PDGF-induced growth of human glomerular mesangial cells via A2B receptors","volume":"46","author":"Dubey","year":"2005","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.lfs.2020.118834_bb0520","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1681\/ASN.2010080890","article-title":"A2B adenosine receptor\u2013 mediated induction of IL-6 promotes CKD","volume":"22","author":"Dai","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.lfs.2020.118834_bb0525","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000381515","article-title":"Hypoxia and dysregulated angiogenesis in kidney disease","volume":"1","author":"Tanaka","year":"2015","journal-title":"Kidney dis"},{"issue":"7","key":"10.1016\/j.lfs.2020.118834_bb0530","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1681\/ASN.2006010075","article-title":"Increased expression of vascular endothelial growth factor in kidney leads to progressive impairment of glomerular functions","volume":"18","author":"Liu","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.lfs.2020.118834_bb0535","doi-asserted-by":"crossref","first-page":"916","DOI":"10.3109\/0886022X.2014.900404","article-title":"The effects of adenosine A2B receptor inhibition on VEGF and nitric oxide axis-mediated renal function in diabetic nephropathy","volume":"36","author":"Patel","year":"2014","journal-title":"Ren. Fail."},{"issue":"19","key":"10.1016\/j.lfs.2020.118834_bb0540","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1016\/j.febslet.2009.09.003","article-title":"Adenosine mediates transforming growth factor- beta 1 release in kidney glomeruli of diabetic rats","volume":"583","author":"Roa","year":"2009","journal-title":"FEBS Lett."},{"issue":"11","key":"10.1016\/j.lfs.2020.118834_bb0545","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-018-1178-5","article-title":"MiR-27b i. regulates podocyte survival through targeting adenosine receptor 2B in podocytes from non-human primate","volume":"9","author":"Zheng","year":"2018","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.lfs.2020.118834_bb0550","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1476-5381.1992.tb14505.x","article-title":"Characterization of adenosine receptors in brush-border membranes from pig kidney","volume":"107","author":"Blanco","year":"1992","journal-title":"Br. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.lfs.2020.118834_bb0555","doi-asserted-by":"crossref","first-page":"F1020","DOI":"10.1152\/ajprenal.00422.2014","article-title":"Identification and function of adenosine A3 receptor in afferent arterioles","volume":"308","author":"Lu","year":"2015","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"2","key":"10.1016\/j.lfs.2020.118834_bb0560","doi-asserted-by":"crossref","first-page":"F267","DOI":"10.1152\/ajprenal.00271.2002","article-title":"A3 adenosine receptor knockout mice are protected against ischemia-and myoglobinuria-induced renal failure","volume":"284","author":"Lee","year":"2003","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"5","key":"10.1016\/j.lfs.2020.118834_bb0565","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.ajpath.2013.07.010","article-title":"The selective A3AR antagonist LJ-1888 ameliorates UUO-induced tubulointerstitial fibrosis","volume":"183","author":"Lee","year":"2013","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.lfs.2020.118834_bb0570","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0016-5085(98)70207-0","article-title":"Natriuretic effect of an adenosine-1 receptor antagonist in cirrhotic patients with ascites","volume":"115","author":"Stanley","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2020.118834_bb0575","first-page":"157","article-title":"Complications of cirrhosis","volume":"32","author":"Arroyo","year":"2000","journal-title":"II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem. J Hepatol."},{"issue":"6","key":"10.1016\/j.lfs.2020.118834_bb0580","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/BF00607083","article-title":"Renal effects of aminophylline in hepatic cirrhosis","volume":"24","author":"Milani","year":"1983","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.lfs.2020.118834_bb0585","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0168-8278(92)90063-U","article-title":"Effects of theophylline on hemodynamics and tissue oxygenation in patients with cirrhosis","volume":"15","author":"Moreau","year":"1992","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.lfs.2020.118834_bb0590","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/ki.2010.204","article-title":"Adenosine A1 receptor antagonists in clinical research and development","volume":"78","author":"Hocher","year":"2010","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.lfs.2020.118834_bb0595","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2165\/11594680-000000000-00000","article-title":"The safety of an adenosine A 1-receptor antagonist, Rolofylline, in patients with acute heart failure and renal impairment","volume":"35","author":"Teerlink","year":"2012","journal-title":"Drug Saf."},{"issue":"8","key":"10.1016\/j.lfs.2020.118834_bb0600","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1161\/01.RES.0000094744.88220.62","article-title":"Activation of adenosine A1 receptor attenuates cardiac hypertrophy and prevents heart failure in murine left ventricular pressure-overload model","volume":"93","author":"Liao","year":"2003","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.lfs.2020.118834_bb0605","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1006\/phrs.1996.0120","article-title":"Cardioprotective effects of adenosine A1 and A2A receptor agonists in the isolated rat heart","volume":"35","author":"Lozza","year":"1997","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.lfs.2020.118834_bb0610","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0022-2828(90)90970-D","article-title":"Adenosine A1 receptor mediated protection of the globally ischemic isolated rat heart","volume":"22","author":"Lasley","year":"1990","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"4","key":"10.1016\/j.lfs.2020.118834_bb0615","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/jcph.828","article-title":"Safety and tolerability of neladenoson bialanate, a novel oral partial adenosine A1 receptor agonist, in patients with chronic heart failure","volume":"57","author":"Voors","year":"2017","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.lfs.2020.118834_bb0620","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/jcph.9","article-title":"Reduction of free fatty acids, safety, and pharmacokinetics of oral GS9667, an A1 adenosine receptor partial agonist","volume":"53","author":"Staehr","year":"2013","journal-title":"J. Clin. Pharmacol."},{"issue":"30","key":"10.1016\/j.lfs.2020.118834_bb0625","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.2174\/092986710792927831","article-title":"Allosteric enhancers of A1 adenosine receptors: state of the art and new horizons for drug development","volume":"17","author":"Romagnoli","year":"2010","journal-title":"Curr. Med. Chem."},{"issue":"6","key":"10.1016\/j.lfs.2020.118834_bb0630","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2174\/138955707780859459","article-title":"Allosteric enhancers for A1 adenosine receptor","volume":"7","author":"Baraldi","year":"2007","journal-title":"Mini-Rev. Med. Chem."},{"issue":"2","key":"10.1016\/j.lfs.2020.118834_bb0635","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.ddtec.2012.08.005","article-title":"Allosteric modulation of A1-adenosine receptor: a review","volume":"10","author":"Kimatrai-Salvador","year":"2013","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.lfs.2020.118834_bb0640","doi-asserted-by":"crossref","unstructured":"May, L.T., Leach, K., Sexton, P.M. and Christopoulos, A., 2007. Allosteric modulation of G protein\u2013 coupled receptors. Annu. Rev. Pharmacol. Toxicol., 47, pp.1\u201351. doi.org\/https:\/\/doi.org\/10.1146\/annurev.pharmto.","DOI":"10.1146\/annurev.pharmtox.47.120505.105159"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520315873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520315873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:36:50Z","timestamp":1758400610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320520315873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":128,"alternative-id":["S0024320520315873"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118834","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cAdenosine an old player with new possibilities in kidney diseases\u201d: Preclinical evidences and clinical perspectives","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118834","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"118834"}}